These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32182693)

  • 21. Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy.
    Bernhardt D; Aufderstrasse S; König L; Adeberg S; Bozorgmehr F; Christopoulos P; Shafie RAE; Hörner-Rieber J; Kappes J; Thomas M; Herth F; Steins M; Debus J; Rieken S
    Cancer Manag Res; 2018; 10():6563-6569. PubMed ID: 30555261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients.
    Shang Z; Wang J; Wang X; Yan H; Cui B; Jia C; Wang Q; Cui X; Li J; Ou T
    Cancer Manag Res; 2018; 10():1177-1190. PubMed ID: 29795989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-Reactive Protein as a New Prognostic Factor for Survival in Patients With Pancreatic Neuroendocrine Neoplasia.
    Wiese D; Kampe K; Waldmann J; Heverhagen AE; Bartsch DK; Fendrich V
    J Clin Endocrinol Metab; 2016 Mar; 101(3):937-44. PubMed ID: 26678655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection.
    Wei Z; Mao R; Zhang Y; Bi X; Zhou J; Li Z; Huang Z; Chen X; Zhao J; Zhao H; Cai J
    Ann Transl Med; 2021 Feb; 9(3):250. PubMed ID: 33708877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic outcome after second primary lung cancer in patients with previously treated lung cancer by radiotherapy.
    Wu Y; Han C; Zhu J; Chong Y; Liu J; Gong L; Liu Z; Hu K; Zhang F
    J Thorac Dis; 2020 Oct; 12(10):5376-5386. PubMed ID: 33209371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib.
    Lee JM; Lee HS; Hyun JJ; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Um SH; Kim CD
    World J Gastrointest Oncol; 2016 Jul; 8(7):555-62. PubMed ID: 27559435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High postoperative neutrophil-to-lymphocyte ratio as a poor prognostic marker in patients with upper tract urothelial carcinoma.
    Nishihara K; Suekane S; Ueda K; Nakiri M; Matsuo M; Igawa T
    Oncol Lett; 2019 Jun; 17(6):5241-5250. PubMed ID: 31186740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma.
    Pan Q; Wei M; Lu M; Xu Y; Xie X; Li X
    Cancer Manag Res; 2023; 15():233-243. PubMed ID: 36873254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy.
    Delago D; Knittelfelder O; Jakse G; Lukasiak K; Reinisch S; Renner W; Stranzl-Lawatsch H; Partl R; Langsenlehner T
    Radiat Oncol; 2020 Nov; 15(1):259. PubMed ID: 33160368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients.
    Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Ploner F; Stojakovic T; Leithner A; Pichler M
    PLoS One; 2014; 9(9):e107297. PubMed ID: 25207808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio.
    Chen S; Yang X; Feng JF
    Oncotarget; 2016 Sep; 7(38):62123-62132. PubMed ID: 27557504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis.
    Huang Y; Liu JS; Feng JF
    Onco Targets Ther; 2015; 8():795-803. PubMed ID: 25914550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum C-reactive protein and overall survival of patients with osteosarcoma.
    Li X; Tian F; Wang F; Li Y
    Tumour Biol; 2015 Jul; 36(7):5663-6. PubMed ID: 25986475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Implications of C-Reactive Protein as a Prognostic Marker in Advanced Cancer Patients in Palliative Care Settings.
    Amano K; Maeda I; Morita T; Miura T; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Nagaoka H; Mori M; Kinoshita H
    J Pain Symptom Manage; 2016 May; 51(5):860-7. PubMed ID: 26826676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy.
    Tao CJ; Chen YY; Jiang F; Feng XL; Jin QF; Jin T; Piao YF; Chen XZ
    J Cancer; 2016; 7(14):2005-2011. PubMed ID: 27877215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
    Dalpiaz O; Ehrlich GC; Mannweiler S; Hernández JM; Gerger A; Stojakovic T; Pummer K; Zigeuner R; Pichler M; Hutterer GC
    BJU Int; 2014 Sep; 114(3):334-9. PubMed ID: 24053693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib.
    Beuselinck B; Vano YA; Oudard S; Wolter P; De Smet R; Depoorter L; Teghom C; Karadimou A; Zucman-Rossi J; Debruyne PR; Van Poppel H; Joniau S; Lerut E; Strijbos M; Dumez H; Paridaens R; Van Calster B; Schöffski P
    BJU Int; 2014 Jul; 114(1):81-9. PubMed ID: 24215209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
    Bergamino M; Rullan AJ; Saigí M; Peiró I; Montanya E; Palmero R; Ruffinelli JC; Navarro A; Arnaiz MD; Brao I; Aso S; Padrones S; Cardenal F; Nadal E
    BMC Cancer; 2019 Feb; 19(1):165. PubMed ID: 30791870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association between D-Dimer and Prognosis in the Patients with Oral Cancer.
    Yamagata K; Fukuzawa S; Ishibashi-Kanno N; Uchida F; Yanagawa T; Bukawa H
    Dent J (Basel); 2020 Aug; 8(3):. PubMed ID: 32756384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors.
    He X; Li JP; Liu XH; Zhang JP; Zeng QY; Chen H; Chen SL
    J Cancer; 2018; 9(10):1877-1884. PubMed ID: 29805715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.